[go: up one dir, main page]

TR201819202A2 - Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon - Google Patents

Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon

Info

Publication number
TR201819202A2
TR201819202A2 TR2018/19202A TR201819202A TR201819202A2 TR 201819202 A2 TR201819202 A2 TR 201819202A2 TR 2018/19202 A TR2018/19202 A TR 2018/19202A TR 201819202 A TR201819202 A TR 201819202A TR 201819202 A2 TR201819202 A2 TR 201819202A2
Authority
TR
Turkey
Prior art keywords
agent
multiple sclerosis
combination containing
muscle relaxing
muscle
Prior art date
Application number
TR2018/19202A
Other languages
English (en)
Inventor
Toksöz Ahmet
Toksöz Zafer
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2018/19202A priority Critical patent/TR201819202A2/tr
Priority to EP19894906.7A priority patent/EP3893855A4/en
Priority to PCT/TR2019/050960 priority patent/WO2020122839A2/en
Publication of TR201819202A2 publication Critical patent/TR201819202A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut buluş, bir multipl skleroz ajanı ve en az bir kas gevşetici 5 ajan içeren bir farmasötik kombinasyon ile ilgilidir, burada multipl skleroz ajanı, teriflunomid veya fampiridindir.
TR2018/19202A 2018-12-12 2018-12-12 Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon TR201819202A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2018/19202A TR201819202A2 (tr) 2018-12-12 2018-12-12 Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon
EP19894906.7A EP3893855A4 (en) 2018-12-12 2019-11-15 COMBINATION COMPRISING AN AGENT AGAINST MULTIPLE SCLEROSIS AND AT LEAST ONE MUSCLE RELAXANT AGENT
PCT/TR2019/050960 WO2020122839A2 (en) 2018-12-12 2019-11-15 A combination comprising a multiple sclerosis agent and at least one muscle relaxant agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2018/19202A TR201819202A2 (tr) 2018-12-12 2018-12-12 Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon

Publications (1)

Publication Number Publication Date
TR201819202A2 true TR201819202A2 (tr) 2020-06-22

Family

ID=71075654

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/19202A TR201819202A2 (tr) 2018-12-12 2018-12-12 Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon

Country Status (3)

Country Link
EP (1) EP3893855A4 (tr)
TR (1) TR201819202A2 (tr)
WO (1) WO2020122839A2 (tr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508715A (en) * 1981-07-01 1985-04-02 University Of Georgia Research Foundation, Inc. Antagonism of central nervous system drugs by the administration of 4-aminopyridine alone or in combination with other drugs
WO2010103544A2 (en) * 2009-03-09 2010-09-16 Dinesh Shantilal Patel A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
WO2016073510A1 (en) 2014-11-04 2016-05-12 Adamas Pharmaceuticals, Inc. Methods of administering amantadine compositions
WO2017031276A1 (en) * 2015-08-19 2017-02-23 The Regents Of The University Of California Methods of providing neuroprotective therapy related to administering an estrogen receptor beta ligand
US11007192B2 (en) * 2016-11-07 2021-05-18 Metriopharm Ag Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis
TR201720406A2 (tr) * 2017-12-14 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar

Also Published As

Publication number Publication date
WO2020122839A2 (en) 2020-06-18
EP3893855A2 (en) 2021-10-20
WO2020122839A3 (en) 2021-02-18
EP3893855A4 (en) 2022-08-17

Similar Documents

Publication Publication Date Title
MX2020005063A (es) Inhibidores de kras g12c.
CY1123678T1 (el) Χρηση αναστολεων μυοστατινης και θεραπειες συνδυασμου
BR112018006259A2 (pt) "adjunto compressível com estruturas de suporte intermediárias"
MX382339B (es) Inhibidores g12c de kras.
MX2024000349A (es) Compuestos y usos de los mismos.
NI202100018A (es) Moduladores de la expresión de pnpla3
CO2019011265A2 (es) Moduladores de la expresión de pcsk9
CO2022000270A2 (es) Inhibidores de enzimas
MX2019008972A (es) Estructura de nucleo-envoltura, preparacion, medicina para aplicacion externa, agente de cinta y producto cosmetico.
TR201819197A2 (tr) Bi̇r multi̇pl skleroz ajani ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon
MX390941B (es) Combinacion farmaceutica que comprende ponesimod.
TR201720406A2 (tr) Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar
MX383386B (es) Nuevos inhibidores de braf y uso de los mismos para el tratamiento de reacciones cutáneas.
TR201819202A2 (tr) Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon
BR112018014069A2 (pt) uso de uma dieta de reforço e imitação de jejum, uso de uma dieta de reforço e imitação de jejum com um agente quimioterápico, e pacote de dieta.
TR201914043A1 (tr) Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari
TR201720515A2 (tr) Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu
CA3064006C (en) Modified release pharmaceutical compositions of huperzine and methods of using the same
MA45718A (fr) Combinaison d'un inhibiteur de bcl-2 et d'un inhibiteur de mcl-1, utilisations et compositions pharmaceutiques associées
CO2020003134A2 (es) Moduladores de la expresión de enac
MA54222A (fr) Combinaison d'un inhibiteur de mcl-1 et de midostaurine, utilisations et compositions pharmaceutiques associées
TR201818859A2 (tr) Di̇meti̇l fumarat ve en az bi̇r kas gevşeti̇ci̇ ajan i̇çeren bi̇r kombi̇nasyon
MA47198A (fr) Combinaison d'un inhibiteur de mcl-1 et d'un composé de taxane, ses utilisations et compositions pharmaceutiques la comprenant
TR201101809A1 (tr) Vildagliptin ve glimepirid kombinasyonları.
BR112018072255A2 (pt) azasteroides para tratamento de tuberculose